TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State July 30, 1993
TCL Archive Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture April 7, 1978
